Triple negative breast cancers (TNBCs) are highly aggressive, do not respond to conventional hormonal interventions due to the lack of the respective receptor targets, have chances of early recurrence, metastasize, tend to be more invasive in nature, develop drug resistance and they are also characterized by the over-expression of the transcription factor NF-κB [7]. This evidence concerns the gene NFKB1 and triple-negative breast carcinoma.